Basit öğe kaydını göster

Ischemia-modified albumin in gynecology

dc.contributor.authorKıncı, Mehmet Ferdi
dc.contributor.authorKasap, Burcu
dc.contributor.authorSivaslıoğlu, Ahmet Akın
dc.date.accessioned2021-03-16T10:10:25Z
dc.date.available2021-03-16T10:10:25Z
dc.date.issued2021en_US
dc.identifier.citationKıncı MF, Kasap B, Sivaslıoğlu AA. Ischemia-modified albumin in gynecology. Biomark Med. 2021 Mar 12. doi: 10.2217/bmm-2020-0616. Epub ahead of print. PMID: 33709783.en_US
dc.identifier.urihttps://doi.org/10.2217/bmm-2020-0616
dc.identifier.urihttps://hdl.handle.net/20.500.12809/9015
dc.description.abstractBackground: Ischemia-modified albumin (IMA) is an oxidative stress marker used to assess the presence and severity of oxidative stress. This marker was first used for early diagnosis of myocardial ischemia. Materials & methods: A variety of IMA studies were carried out to show the effect of oxidative stress on gynecological disorders. Conclusion: This analysis summarizes the literature by conducting electronic research on the relationship between IMA and gynecological disordersen_US
dc.item-language.isoengen_US
dc.publisherFuture Medicineen_US
dc.relation.isversionof10.2217/bmm-2020-0616en_US
dc.item-rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectIVFen_US
dc.subjectPCOSen_US
dc.subjectEndometriosisen_US
dc.subjectGynecologyen_US
dc.subjectİschemia-modified albuminen_US
dc.subjectMenopauseen_US
dc.titleIschemia-modified albumin in gynecologyen_US
dc.item-typereviewen_US
dc.contributor.departmentMÜ, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümüen_US
dc.contributor.authorID0000-0003-0487-1201en_US
dc.contributor.institutionauthorKıncı, Mehmet Ferdi
dc.contributor.institutionauthorKasap, Burcu
dc.contributor.institutionauthorSivaslıoğlu, Ahmet Akın
dc.relation.journalBiomarkers in Medicineen_US
dc.relation.publicationcategoryDiğeren_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster